The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States
Zachary S. Wallace(Amgen (United States)), Hyon K. Choi(Massachusetts General Hospital), Yuqing Zhang(Shihezi University), John H. Stone(Twitter (United States)), Gandarvaka Miles(Sanofi (United States)), Ekaterina Smolkina(Sanofi (Netherlands)), Krishan Guzzo(Massachusetts General Hospital), Xiaoqing Fu(Yunnan Center for Disease Control And Prevention), Duane Madziva(Sanofi (United States)), Claire Cook(Massachusetts General Hospital), Natalia Petruski‐Ivleva(AVEO Oncology (United States))
Cited by 9
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
|New England Journal of Medicine|2004|1.2k
Alcohol intake and risk of incident gout in men: a prospective study
|The Lancet|2004|748
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
|The American Journal of Medicine|2012|661